Company Filing History:
1 out of 27,246 
1 out of 372 
1 out of 27 
Years Active: 2001-2025
Title: The Innovations of Bin Li
Introduction
Bin Li is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of methods for preparing porcine-derived interferon-delta 5. With a total of seven patents to his name, his work has implications for veterinary medicine and the treatment of viral infections in pigs.
Latest Patents
Among his latest patents is a method for preparing porcine-derived interferon-delta 5 (pIFN-δ5). This innovative method involves several steps, including obtaining a DNA fragment containing the pIFN-δ5 gene through reverse transcription-polymerase chain reaction (RT-PCR) amplification. The process continues with the insertion of this DNA fragment into an exogenous expression vector, ultimately leading to the expression of the pIFN-δ5 gene in a suitable host cell. The recombinant pIFN-δ5 protein produced is intended for use in developing drugs to inhibit infections caused by various porcine viruses, including porcine epidemic diarrhea virus (PEDV) and porcine rotavirus (PRoV).
Career Highlights
Bin Li has worked with notable organizations such as Huawei Technologies Co., Limited and Southeast University. His experience in these institutions has allowed him to collaborate with leading experts in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Baochao Fan and Shiying Song. Their collaborative efforts have contributed to the advancement of research in biotechnology and the development of innovative solutions for animal health.
Conclusion
Bin Li's work exemplifies the impact of innovation in biotechnology, particularly in addressing challenges in veterinary medicine. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for viral infections in livestock.